SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biogen
BIIB 187.63+0.9%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rick Lundberg who wrote (25)9/11/1996 5:53:00 PM
From: Harold Engstrom   of 1686
 
Thanks Rick. The question about Hirulog was just out of curiousity, I didn't think that there would be any developments forthcoming, although one would be nice. Hirulog has two significant advantages over Heparin: it doesn't have a half-life of 5 minutes like Heparin, and it could be used to coat foreign surfaces like medical devices while Heparin is too non-uniform to work in that capacity. I hope Biogen can make something out of the product.

Harold Engstrom
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News